Kensington, MD, United States of America

John Todd Schiller

This inventor holds 1 USPTO granted patent. Top assignees: Aura Biosciences, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Todd Schiller. Retrieved from https://idiyas.com/inventor/john-todd-schiller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Todd Schiller: Inventor in Cancer Immunotherapy

Introduction

John Todd Schiller is an inventor associated with Kensington, Maryland. His patent work concerns approaches to treating tumors by combining immunotherapy with targeted viral nanoparticle technologies.

Latest Patents

Schiller is listed on 1 patent: “Methods for Treating Bladder Tumors with Viral Nanoparticle Conjugates and Immune Checkpoint Inhibitors.” The disclosure describes methods and compositions that combine immunotherapeutic agents with tumor-targeting viral capsid protein assemblages. These assemblages comprise anticancer molecules conjugated to viral capsid proteins, with the aim of treating tumors.

Career Highlights

The organizations associated with Schiller’s work include Aura Biosciences, Inc., and the United States Department of Health and Human Services. His patent reflects research at the intersection of targeted delivery and immune-based cancer treatment.

Collaborations

Schiller’s listed coworkers include Elisabet De Los Pinos and Rhonda C. Kines. Their names appear among the professional connections associated with his work.

Conclusion

John Todd Schiller’s patent focuses on combining viral nanoparticle conjugates with immune checkpoint inhibitors as a potential approach to treating bladder tumors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…